Belong.Life provides a digital health platform that combines AI-driven health mentors and extensive patient communities to support individuals with cancer and multiple sclerosis. The platform addresses the need for continuous, personalized healthcare guidance and community engagement, enhancing patient outcomes and streamlining care management.
Funding
$20M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Individuals managing chronic diseases like cancer and multiple sclerosis often lack continuous, personalized guidance and struggle with feelings of isolation. Existing healthcare systems may not provide sufficient support for patients to navigate their complex conditions and treatment options effectively. This can lead to poorer health outcomes and a diminished quality of life.
Solution
Belong.Life offers a digital health platform that combines AI-driven health mentors with social and professional communities to provide comprehensive support for individuals with chronic diseases. The platform delivers personalized guidance, proactive support, and educational resources, empowering patients to actively manage their health. By connecting patients with peers and healthcare professionals, Belong.Life fosters a sense of community and shared experience, enhancing patient outcomes and streamlining care management. The BelongAI health mentor app provides 24/7 support and functions as a health case manager, offering proactive assistance and connecting users with relevant communities.
Target Audience
The primary target audience includes individuals living with chronic diseases such as cancer, multiple sclerosis and IBD, as well as healthcare providers, pharmaceutical companies, and payers seeking to improve patient engagement and outcomes.
Features
- AI-powered health mentors providing personalized guidance and support
- Social and professional networks for cancer and multiple sclerosis patients
- AI-driven clinical trial matching
- Integration of medically validated information from renowned oncologists at ASCO and ESMO
- Proactive support and guidance validated by physicians and powered by a community of peers
- Mobile applications for both iOS and Android platforms
- Compliant with ISO/IEC 27001:2013, ISO 27799:2016, HIPAA, and GDPR standards